Ignite Creation Date:
2025-12-18 @ 8:30 AM
Ignite Modification Date:
2025-12-23 @ 9:56 PM
Study NCT ID:
NCT05124912
Status:
None
Last Update Posted:
2025-08-29 00:00:00
First Post:
2021-10-26 00:00:00
Is Possible Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
REMASTer: REcurrent Brain Metastases After SRS Trial
Sponsor:
None
Organization:
Study Overview
Official Title:
REMASTer: REcurrent Brain Metastases After SRS Trial
Status:
None
Status Verified Date:
2025-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Randomized, post-market multi-center study investigating the efficacy of two sets of treatment algorithms in brain metastases (BM) patients at the time of first intervention for radiographic progression after stereotactic radiosurgery (SRS), with or without surgery.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: